DRL in agreement with Eisai Co, Japan
Acquires rights to Investigational Anticancer Agent E7777 for US, Europe and certain emerging markets from Eisai
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
agreement
Recipharm signs agreement with Daewoong
Secures €25 million contract for Erdosteine API
Clariant plans to acquire part of Vivimed Labs’ personal care portfolio
The acquisition will enable Clariant India to strengthen its personal care portfolio within the ICS business
Clariant has…
DRL partners with PanTheryx
To market PanTheryx’s proprietary nutritional intervention for paediatric infectious diarrhoea
PanTheryx, a global medical…
Sun Pharma in distribution agreement with AstraZeneca for brand Axcer
Sun Pharma will be promoting and distributing Axcer brand in India
DRL to acquire select portfolio of UCB’s products business in India
The revenues of the acquired business is approximately Rs 150 crores for calendar year 2014